-
Relationship between Dose, Factor IX Activity Levels and Bleeding Probability for rIX-FP Prophylaxis in Hemophilia B: A Repeated Time-to-Event Analysis
Koopman, S. F., Cnossen, M. H., Mathot, R. A. A. & the OPTI-CLOT study group and SYMPHONY consortium, Oct 2025, In: Clinical Pharmacology and Therapeutics. 118, 4, p. 831-840 10 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Proteolytic signatures of coagulation identified by plasma peptidomics
del Castillo Alferez, J., Kooiker, A., van Alphen, F. P. J., van der Zwaan, C., Brinkman, H.-J., Meijers, J. C. M., Meijer, A. B., van den Biggelaar, M., van Duijl, T. T. & SYMPHONY consortium, Aug 2025, In: Journal of Thrombosis and Haemostasis. 23, 8, p. 2494-2507 14 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Proteomic analysis indicates lower abundance of platelet α-granule proteins in Glanzmann thrombasthenia
Zivkovic, M., Shamorkina, T. M., Blaauwgeers, M. W., Post, H., Heck, A. J. R., Schutgens, R. E. G., Urbanus, R. T., Thrombocytopathy in the Netherlands (TiN) study group & SYMPHONY consortium, Jul 2025, In: Journal of Thrombosis and Haemostasis. 23, 7, p. 2284-2296 13 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
